Home›People›Mark Summers
Mark Summers

Mark Summers

Chairman of AngioInsight

DirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Nov 10, 2026·Suggest an edit

About Mark Summers

Mark Summers chairs AngioInsight, which develops investigational AI software to help clinicians assess angiograms. He has at least 40 years of health care startup experience. He founded ThreeWire and served as its chief executive officer before its sale to WIRB-Copernicus Group. Four early-stage companies he led became $1 billion-plus companies.

Experience

This experience comes from official bios, from Mark Summers's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mark Summers in the role, so the role may have started earlier or lasted longer.

AngioInsight, Inc. Current
Chairman of the Board of Directors
2026 – Present · Minnetonka, MN
Its investigational software helps cardiologists assess artery narrowing, blood flow, and small-vessel disease from routine angiograms.
Avio Medtech Consulting Current
Board Member
2024 – Present
83Bar, Inc. Current
Director
2022 – Present · Austin, TX
Azura Bio, Inc. Current
Board Member
2021 – Present
Dosentrx Current
Chairman & CEO
2016 – Present
UroCure LLC
Board Member
2020 – 2025
WCG
President, Patient Engagement Division
2018 – 2020
Sulzer Spine-Tech
Vice President of Global Marketing
1998 – 1999
Spine-Tech, Inc.
National Sales Director
1996 – 1998
Alcon Laboratories, Inc.
Group Marketing Director, Surgical Division
1987 – 1996
American Hospital Supply Corporation
Sales
1983 – 1987
US Navy
Naval Aviation
1977 – 1983
ThreeWire
Founder & CEO

Key Colleagues at Startups

The people Mark Summers works with at each company, as listed on that company's latest Form D.

AngioInsight, Inc. · Form D, Nov 10, 2026
Scott Burger
Scott Burger
Chief Executive Officer and director
Serafin Samson
Serafin Samson
Co-Founder and director
83Bar, Inc. · Form D, Dec 31, 2025
SN
Seth Nelson
Executive officer and director
RB
RR
Robert Rebak
Director
RS
Randy Scott
Director
TH
Terry O'Hara
Chief Financial Officer

Sources

  1. SECAngioInsight, Inc. Form D, filed Nov 10, 2026
  2. SEC83Bar, Inc. Form D, filed Dec 31, 2025
  3. P2AngioInsight CEO appointment release
  4. P3AngioInsight home page